Goodwill And Other Intangibles (Schedule Of Other Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2015
Indefinite-lived intangibles:
Balance		$ 1,742,880
Acquisitions		34,691
Intangible asset impairment		(55,100)
Other		(138,456)
Effect of Currency Translation		2,594
Balance	$ 1,437,718	1,437,718
Definite-lived intangibles:
Balance		7,427,295
Acquisitions		34,691
Impairments		(219,654)
Other		(95,387)
Effect of Currency Translation		24,136
Balance	7,285,281	7,285,281
Total other intangibles
Beginning balance		9,170,175
Impairment of intangible assets		(274,754)
Other		(233,843)
Effect of Currency Translation		26,730
Ending balance	8,722,999	8,722,999
Accumulated amortization:
Balance		(1,341,233)
Amortization		(636,061)
Impairments		0
Other		232,206
Effect of Currency Translation		(2,333)
Balance	(1,747,421)	(1,747,421)
Net other intangibles	6,975,578	6,975,578	$ 7,828,942
Astora
Definite-lived intangibles:
Impairments		(10,000)
Total other intangibles
Impairment of intangible assets		(16,300)
U.S. Generic Pharmaceuticals
Total other intangibles
Impairment of intangible assets		(169,600)
U.S. Branded Pharmaceuticals
Definite-lived intangibles:
Impairments		$ (221,900)
Total other intangibles
Impairment of intangible assets	(72,800)
International Pharmaceuticals
Total other intangibles
Impairment of intangible assets	(16,200)
Weighted Average
Accumulated amortization:
Intangible life (years)		12 years
Indefinite-lived Intangibles
Indefinite-lived intangibles:
Acquisitions		$ (114,200)
Definite-lived intangibles:
Acquisitions		(114,200)
Definite-Lived Intangibles
Indefinite-lived intangibles:
Acquisitions		148,891
Definite-lived intangibles:
Acquisitions		148,891
Licenses
Definite-lived intangibles:
Balance		676,867
Impairments		0
Other		(211,147)
Effect of Currency Translation		0
Balance	465,720	465,720
Accumulated amortization:
Balance		(508,225)
Amortization		(37,142)
Impairments		0
Other		211,147
Effect of Currency Translation		0
Balance	(334,220)	$ (334,220)
Licenses | Weighted Average
Accumulated amortization:
Intangible life (years)		12 years
Licenses | Definite-Lived Intangibles
Indefinite-lived intangibles:
Acquisitions		$ 0
Definite-lived intangibles:
Acquisitions		0
Customer Relationships
Definite-lived intangibles:
Balance		11,318
Impairments		(3,460)
Other		(7,858)
Effect of Currency Translation		0
Balance	0	0
Accumulated amortization:
Balance		(7,858)
Amortization		0
Impairments		0
Other		7,858
Effect of Currency Translation		0
Balance	0	$ 0
Customer Relationships | Weighted Average
Accumulated amortization:
Intangible life (years)		15 years
Customer Relationships | Definite-Lived Intangibles
Indefinite-lived intangibles:
Acquisitions		$ 0
Definite-lived intangibles:
Acquisitions		0
Tradenames
Definite-lived intangibles:
Balance		7,537
Impairments		0
Other		0
Effect of Currency Translation		(127)
Balance	7,410	7,410
Accumulated amortization:
Balance		(6,544)
Amortization		(66)
Impairments		0
Other		0
Effect of Currency Translation		19
Balance	(6,591)	$ (6,591)
Tradenames | Weighted Average
Accumulated amortization:
Intangible life (years)		12 years
Tradenames | Definite-Lived Intangibles
Indefinite-lived intangibles:
Acquisitions		$ 0
Definite-lived intangibles:
Acquisitions		0
Developed technology
Definite-lived intangibles:
Balance		6,731,573
Impairments		(216,194)
Other		123,618
Effect of Currency Translation		24,263
Balance	6,812,151	6,812,151
Accumulated amortization:
Balance		(818,606)
Amortization		(598,853)
Impairments		0
Other		13,201
Effect of Currency Translation		(2,352)
Balance	(1,406,610)	$ (1,406,610)
Developed technology | Weighted Average
Accumulated amortization:
Intangible life (years)		12 years
Developed technology | Definite-Lived Intangibles
Indefinite-lived intangibles:
Acquisitions		$ 148,891
Definite-lived intangibles:
Acquisitions		148,891
In-process research and development
Indefinite-lived intangibles:
Balance		1,742,880
Intangible asset impairment		(55,100)
Other		(138,456)
Effect of Currency Translation		2,594
Balance	$ 1,437,718	1,437,718
In-process research and development | Indefinite-lived Intangibles
Indefinite-lived intangibles:
Acquisitions		(114,200)
Definite-lived intangibles:
Acquisitions		$ (114,200)